Roberto Piva

16PUBLICATIONS
49CO-AUTHORS
Molecular targetsGene and molecular therapyCancer cell biologyHaematological tumoursVeterinary diagnosis and diagnostics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Apr 14, 2026
Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies.

Francesco Edoardo Vallone, Giulia Omezzolli, Matilde Micillo

|Feb 13, 2026
Dual Targeting of IDH2 and the Ubiquitin-Proteasome System Reveals a Functional Vulnerability in Breast Cancer Models.

Nariman Gharari, Elisabetta Mereu, Beatrice Luciano

|Jan 25, 2025
Unlocking the Therapeutic Potential of Algae-Derived Compounds in Hematological Malignancies.

Tamara Vujović, Tina Paradžik, Sanja Babić Brčić

|Oct 16, 2024
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition.

Roberto Piva, Nariman Gharari, Maria Labrador

|May 16, 2023
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines.

Elisabetta Mereu, Damiano Abbo, Tina Paradzik

Pageof 3

Frequent Collaborators

3 joint publications

Tina Paradzik

3 joint publications

Elisa Pellegrino

3 joint publications

Chiara Riganti

3 joint publications

Silvia Deaglio